LOW-DOSE ARA-C AS MAINTENANCE TREATMENT IN AML

被引：0
|
作者：
CATALANO, L
FONTANA, R
SELLERI, C
DEROSA, G
ROTOLI, B
机构：
来源：
HAEMATOLOGICA | 1989年 / 74卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：412 / 413
页数：2
相关论文
共 50 条
  • [21] CELLULAR AND CLINICAL-PHARMACOLOGY OF LOW-DOSE ARA-C
    KUFE, DW
    GRIFFIN, JD
    SPRIGGS, DR
    SEMINARS IN ONCOLOGY, 1985, 12 (02) : 200 - 207
  • [22] LOW-DOSE ARA-C IN MYELODYSPLASTIC SYNDROMES AND CML IN TRANSFORMATION
    KRIEGER, O
    BERNHART, M
    MRSTIK, C
    NOWOTNY, H
    LUTZ, D
    BLUT, 1985, 51 (03): : 162 - 162
  • [23] CYTOGENETICS ARE A PREDICTIVE FACTOR OF RESPONSE TO LOW-DOSE ARA-C IN ACUTE MYELOGENOUS LEUKEMIA (AML) IN THE ELDERLY
    FENAUX, P
    LAI, JL
    GARDIN, C
    BAUTERS, F
    LEUKEMIA, 1990, 4 (04) : 312 - 312
  • [24] The addition of arsenic trioxide to low-dose Ara-C in older patients with AML does not improve outcome
    A K Burnett
    R K Hills
    A Hunter
    D Milligan
    J Kell
    K Wheatley
    J Yin
    M-F McMullin
    P Cahalin
    J Craig
    D Bowen
    N Russell
    Leukemia, 2011, 25 : 1122 - 1127
  • [25] Low Dose Ara-C Versus Low Dose Ara-C and Tipifarnib: Result of the UK NCRI AML16 "Pick a Winner" Comparison
    Burnett, Alan K.
    Hills, Robert
    Milligan, Donald
    Kell, William J.
    Wheatley, Keith
    Virchis, Andres E.
    Russell, Nigel H.
    BLOOD, 2008, 112 (11) : 1017 - 1018
  • [26] Hematological Improvement in AML/RAEB Elderly Patients Treated with Valproic Acid and Low-Dose ARA-C
    Corsetti, Maria Teresa
    Salvi, Flavia
    Perticone, Sonia
    Allione, Bernardino
    Baraldi, Anna
    Bellora, Alessandro
    De Paoli, Lorella
    Gatto, Simona
    Pietrasanta, Daniela
    Primon, Valeria
    Pini, Massimo
    Tonso, Anna
    Musi, Marco
    Ciravegna, Giorgio
    Zallio, Francesco
    Levis, Alessandro
    BLOOD, 2008, 112 (11) : 1020 - 1021
  • [27] The addition of arsenic trioxide to low-dose Ara-C in older patients with AML does not improve outcome
    Burnett, A. K.
    Hills, R. K.
    Hunter, A.
    Milligan, D.
    Kell, J.
    Wheatley, K.
    Yin, J.
    McMullin, M-F
    Cahalin, P.
    Craig, J.
    Bowen, D.
    Russell, N.
    LEUKEMIA, 2011, 25 (07) : 1122 - 1127
  • [28] TREATMENT OF MYELODYPLASTIC SYNDROME (MDS) - LOW-DOSE ARA-C OR MORE AGGRESSIVE CHEMOTHERAPY
    HEYLL, A
    AUL, C
    HEYLL, U
    GATTERMANN, N
    DERIGS, G
    SCHAFERS, M
    PLANKER, M
    SCHNEIDER, W
    BLUT, 1987, 55 (04): : 223 - 223
  • [29] FAVORABLE REMISSION RATE BY REPEATING LOW-DOSE ARA-C TREATMENT IN ANLL AND RAEB
    IZUMI, Y
    SAWADA, H
    OKAZAKI, T
    MOCHIZUKI, T
    ISHIKURA, H
    TASHIMA, M
    YAMAGISHI, M
    UCHINO, H
    BRITISH JOURNAL OF HAEMATOLOGY, 1985, 61 (01) : 187 - 190
  • [30] Low Dose Ara-C Versus Low Dose Ara-C and Arsenic Trioxide: the UK NCRI AML16 "Pick a Winner" Comparison.
    Russell, Nigel H.
    Hills, Robert K.
    Hunter, Ann E.
    Milligan, Donald
    Kell, William J.
    Wheatley, Keith
    McMullin, Mary Frances
    Yin, John A. L.
    Bowen, David T.
    Burnett, A.
    BLOOD, 2009, 114 (22) : 201 - 201
12345